Clinical Trials Search at Vanderbilt-Ingram Cancer Center

A Phase 2 Study of Blinatumomab in Combination with Chemotherapy for Infants with Newly Diagnosed Acute Lymphoblastic Leukemia with Randomization of KMT2A Rearranged Patients to Addition of Venetoclax

Disease Sites:

Leukemia

Staging:

Phase II

Age Group:

Children

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Smith, Brianna

Scope:

National

Participating Institutions:

Vanderbilt University

Open Date:

09-23-2025

Trial Type:

Treatment

Protocol ID:

COGAALL2321

National Clinical Trial ID:

NCT06317662

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available